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Background: The demand for clinically efficacious, safe, patient acceptable, and cost-
effective forms of treatment for mental illness is growing. Several studies have demon-
strated benefit from yoga in specific psychiatric symptoms and a general sense of well-
being.
Objective:To systematically examine the evidence for efficacy of yoga in the treatment of
selected major psychiatric disorders.
Methods: Electronic searches ofThe Cochrane Central Register of ControlledTrials and the
standard bibliographic databases, MEDLINE, EMBASE, and PsycINFO, were performed
through April 2011 and an updated in June 2011 using the keywords yoga AND psychiatry
OR depression OR anxiety OR schizophrenia OR cognition OR memory OR attention AND
randomized controlled trial (RCT). Studies with yoga as the independent variable and one of
the above mentioned terms as the dependent variable were included and exclusion criteria
were applied.
Results:The search yielded a total of 124 trials, of which 16 met rigorous criteria for the final
review. Grade B evidence supporting a potential acute benefit for yoga exists in depression
(four RCTs), as an adjunct to pharmacotherapy in schizophrenia (three RCTs), in children
with ADHD (two RCTs), and Grade C evidence in sleep complaints (three RCTs). RCTs
in cognitive disorders and eating disorders yielded conflicting results. No studies looked
at primary prevention, relapse prevention, or comparative effectiveness versus pharma-
cotherapy.
Conclusion:There is emerging evidence from randomized trials to support popular beliefs
about yoga for depression, sleep disorders, and as an augmentation therapy. Limitations
of literature include inability to do double-blind studies, multiplicity of comparisons within
small studies, and lack of replication. Biomarker and neuroimaging studies, those compar-
ing yoga with standard pharmaco- and psychotherapies, and studies of long-term efficacy
are needed to fully translate the promise of yoga for enhancing mental health.
Keywords: yoga, meditation, depression, schizophrenia, cognition, ADHD, clinical trials, alternative medicine
BACKGROUND
Mental illnesses are asignificant global health concern, despite
improvements in treatment modalities and access to care. The
World Health Organization (WHO, 2011) has estimated that psy-
chiatric disorders are the leading costs of disability adjusted life
years world-wide, with recent figures indicating that 37% of the
loss of healthy years from non-communicable diseases is from
mental illnesses. The National Co-morbidity survey replication
conducted in the United States estimated the 1-year prevalence
of any psychiatric disorder to be 26.2% (Kessler et al., 2008).
According to the WHO, depression ranked third among global
disease burdens all over the world in 2004; it was reportedly
the most important cause in middle and high income countries,
while it ranked eight among the low income countries (World
Health Organization, 2008). Depression was found to result in
the greatest decrement in health, compared to asthma, angina,
arthritis, and diabetes (Maussavi et al., 2007). Prevalence data
for anxiety disorders, suggests that the lifetime prevalence and
12 month prevalence for any anxiety disorder are over 15 and
10%, respectively, with higher prevalence in developed countries
(Kessler et al., 2009). Likewise, schizophrenia has been associated
with significantly higher health care costs, unemployment rate,
and morbidity (Goeree et al., 2005). Sleep complaints are often
associated with a variety of psychiatric disorders. About 9–21% of
the population has been estimated to have insomnia accompanied
by serious day-time consequences which include chronic fatigue,
irritability, low mood, memory impairments, and interpersonal
difficulties (Moul et al., 2002). This problem has reached epidemic
www.frontiersin.org January 2013 | Volume 3 | Article 117 | 1
Balasubramaniam et al. Systematic review of yoga’s benefits
proportions in the United States, where almost 25% of adults con-
sume sleep medications at some point in a year (National Sleep
Foundation, 2005).
The availability of psychopharmacological treatments has
increased, but the response and tolerability remain unpredictable
and inconsistent. While psychotropics agents can be lifesaving
for many people, there remains a considerable unmet need.
The landmark National Institute of Mental health (NIMH)
funded Sequenced Treatment Alternatives to Relieve Depression
(STAR∗D) study showed remission in only one third of major
depression patients after a trial with the first anti-depressant and
worsening response rates with each subsequent trial (Trivedi et al.,
2006). The Primary Care study conducted by WHO found that
60% of the patients continued to meet criteria for depression
after a year of being treated with an anti-depressant (Goldberg
et al., 1998). The Clinical Anti-psychotic Trials of Intervention
Effectiveness (CATIE) demonstrated that 74% of the participants
discontinued from their treatments in 18 months, with a mean
time to discontinuation of 4.6 months (Lieberman et al., 2005).
Treatment resistance is a growing problem and there are millions of
patients world-wide whose depression, anxiety, or schizophrenia
is not fully resolved despite multiple trials of psychopharmaco-
logic agents. Psychotropic medications are costly and suffer from
significant side effects leaving patients and clinicians to struggle to
balance efficacy against cost and side effects, which often leads to
poor compliance and relapse.
Given the heterogeneous nature of psychiatric conditions, with
respect to biological, psychological, and social factors, it is not sur-
prising that available standard treatments often have inconsistent
response rates. The quest and demand for non-pharmacological
treatment modalities has been increasing (Barrows and Jacobs,
2002). A study conducted by the Harris Interactive Service Bureau
revealed that 15.8 million adults in the United States practice yoga,
triple the number in 2004. The holistic goal of yoga to promote
physical and mental health, and also be spiritually and socially con-
scious, may appeal both to consumers and providers who are con-
cerned about the symptom reduction based focus of psychophar-
macology and finding inner peace (Uebelacker et al., 2010). The
barriers to access are low and the diversity of practice styles and set-
tings (e.g., at home versus in gyms versus outdoors) allows consid-
erable degree of personalization. Hence, yoga appears to be a well
suited intervention to test as a potential therapy for major psychi-
atric disorders. However, yoga has also become such a cultural phe-
nomenon that it has become difficult for physicians and consumers
to differentiate legitimate claims from hype. Our goal in this review
was to examine whether the evidence matched the promise.
Yoga, with origins in ancient India has several sub-types
(Table 1; Cook, n.d.), and incorporates physical postures (asanas),
controlled breathing (pranayama), deep relaxation, and medi-
tation (Javnbakht et al., 2009). In addition to low barriers to
access, the scientific rationale for yoga effects on the mind are
quite strong. All yoga practices are known to influence the men-
tal state (Telles, 2010) – studies have noted benefits in children
(Manjunath and Telles, 2004), adults (Vialatte et al., 2008), elderly
(Krishnamurthy and Telles, 2007), and individuals with occupa-
tional stress (Vempati and Telles, 2000). In healthy individuals,
biomarker studies suggest that yoga influences neurotransmitters,
inflammation, oxidative stress, lipids, growth factors, and second
messengers (Figure 1), in a manner largely similar to what has been
shown for anti-depressants and psychotherapy. It is hypothesized
that yoga combines the effects of physical postures, which have
been independently associated with mood changes (Phillips et al.,
2003), and meditation which increases the levels of Brain-derived
neurotrophic factor (BDNF; Xiong and Doraiswamy, 2009). Other
effects that have been noted include increased vagal tone, increased
gamma-aminobutyric acid (GABA) levels, increase in serum
prolactin, downregulation of the hypothalamic-pituitary-adrenal
axis and decrease in serum cortisol, and promotion of frontal
electroencephalogram (EEG) alpha wave activity which improves
relaxation (Janakiramaiah et al., 1998, 2000; Kamei et al., 2000;
Streeter et al., 2007). Lastly, prior clinical studies have noted sev-
eral psychiatric conditions for which yoga has proved beneficial
(Shannahoff-Khalsa et al., 1999; Carei et al., 2010; Visceglia and
Lewis, 2011; Katzman et al., 2012; Libby et al., 2012) but because
of differing methods there is a need to try to synthesize such data
to further the field.
Thus, while the effects of yoga on the spiritual aspects of the
mind (e.g., inner peace) are well documented, its effects in major
clinical psychiatric disorders are less so. The objective of this report
was to systematically review the available literature for the effects
of yoga on major psychiatric disorders. The focus of this review
was primarily categorical disease threshold outcomes (e.g., major
depression), in keeping with how psychiatric disorders are catego-
rized and treated, and how effects of psychopharmacologic inter-
ventions are assessed – rather than on single symptom domains
such as mood or sleep which cut across multiple diagnoses. We
did use symptoms (e.g., depression and memory) as search terms
to ensure our search was comprehensive but restricted our final
review to major disorders that require intervention in practice.
METHODS
SEARCH STRATEGY
Electronic searches of The Cochrane Central Register of Con-
trolled Trials (CENTRAL) and the standard bibliographic data-
bases, MEDLINE, EMBASE, and PsycINFO, was conducted
through April 2011 and updated in June 2011, using the keywords
yoga AND psychiatry OR depression OR anxiety OR schizophre-
nia OR cognition OR memory OR attention AND randomized
controlled trial (RCT). The title and abstract of each citation were
screened based on definite pre-specified inclusion and exclusion
criteria. Full text reading of articles that were potentially eligi-
ble was undertaken. When full-texts were not available, attempts
were made to contact the author. If a reply was not received
within 2 weeks from the corresponding author, abstracts were
read to check if they had the required information. Studies have
been reviewed by all authors and disagreements were resolved by
consensus.
Randomized clinical trials with any sub-type of yoga as the
intervention and one or more of the above mentioned condi-
tions as the outcome of interest were included. Open trials, non-
randomized trials, case series, and dissertations were excluded. The
review includes studies in which subjects have either been formally
diagnosed with a disorder or have reported symptoms suggestive
of the same. Since age is an important risk factor for cognitive
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Table 1 |Table showing the key elements of the different forms of yoga (Cook, n.d.).
Type of yoga Key features
Ashtanga yoga Fast-paced series of sequential posture, based on six series of asanas
Hatha yoga Basic form of yoga which incorporates postures, regulated breathing, and meditation
Iyengar yoga Focuses on the precise alignment of postures
Power yoga Westernization of Ashtanga yoga. Popular in the US
Jivamukti yoga Physically challenging postures, highly meditative
Kali Ray TriYoga Consists of flowing, dance-like movements, often accompanied by music
White Lotus Yoga Consists of flowing movements with varying difficulty levels
Integrated yoga therapy Designed for medical problems. May include meditation and guided imagery
Viniyoga Gentle practice which particularly emphasizes on the synchronization of poses with breathing
Svaroopa Emphasizes on the “opening of the spine beginning at the tailbone progressing through each spinal area”
Bikram Yoga (Hot Yoga) Consists of a series of 26 postures performed in a space with temperature above 100˚F
Phoenix rising yoga therapy Combines traditional yoga with client centered and mind-body psychology, that incorporates non-directive dialog
Sivananda yoga Consists of 12 basic yoga postures along with chanting and meditation
Integral yoga Consists of basic hatha yoga postures
Ananda yoga Consists of basic hatha yoga postures with use of “silent affirmations while holding up a pose”
Kundalini yoga Focuses on awakening the energy at the base of the spine and channeling it upwards
ISHTA yoga Combination of Ashtanga and Iyengar yoga
Kripalu yoga Consists of three stages namely willful practice, willful surrender, and meditation in motion
Anusara yoga Consists of basic hatha yoga postures but emphasizes on attitude, alignment, and action
Tibetan yoga Composed of fine, flowing movements, and controlled breathing
FIGURE 1 | Schematic illustration of potential effects of yoga on biomarkers and end organs based on various sources.The strength of evidence ranges
from strong to preliminary for specific effects as described further in the text. Copyright Doraiswamy and Balasubramaniam, reproduced with permission in this
article.
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Table 2 |Table showing checklist for RCTs according to guidelines
recommended by AHRQ.
Item Points
Study question – clearly focused? 1
Study population 2
Randomization 2
Blinding 2
Interventions 2
Outcomes 2
Statistical analysis 2
Results 1
Discussion (including limitations and biases) 1
Funding source 2
Total 17
Score 100%
impairment, studies examining cognition in the geriatric popula-
tion have been included, even in the absence of formal diagnoses
or specific symptoms. Studies on sub-threshold symptoms such
as general well-being, stress, and coping have been excluded. Out-
comes consisted of self-reported change, scores on rating scales,
acceptability, and tolerance of the treatment.
The quality of RCTs was scored using the guidelines rec-
ommended by the Agency for Healthcare Research and Quality
(AHRQ, 2002), with a maximum possible score of 17. Table 2 illus-
trates the scoring according to the AHRQ guidelines. Study quality
was additionally assessed using the Oxford Center for Evidence-
based Medicine’s (CEBM) Levels of Evidence, which assigns a level
of evidence from 1 to 4, where 1 indicates high quality RCTs, 2
indicates low quality RCTs, 3 suggests case-control studies, and 4
stands for case reports, case series, and low quality case-control
studies (Phillips et al., 2001). Determinants of study quality have
been explained in Table 3. Based on evidence levels obtained by the
Oxford CEBM method, recommendation categories of A (recom-
mended), B (suggested), or C (may be considered) have been spec-
ified for each diagnosis, as indicated by the Research and Devel-
opment/University of California at Los Angeles (RAND/UCLA)
Appropriateness Method (Fitch et al., 2000; Table 4). In the tables
demonstrating details of individual studies for each diagnosis, the
AHRQ scores, evidence level and recommendation levels have been
detailed (Tables 5–9). The review has been prepared using pre-
ferred reporting items for systematic reviews and meta-analyses
(PRISMA) guidelines (Moher et al., 2009).
RESULTS
Sixteen RCTs met criteria for inclusion in our review. Figure 2
illustrates the process of study extraction.
YOGA FOR DEPRESSION
Four RCTs examining the effects of yoga on depression have been
included in this review. Table 5 summarizes each of these studies,
including our assessments of their quality.
Shahidi et al. tested 70 elderly women (mean age of 65 years
in the intervention groups and 68 years among controls) report-
ing subjective symptoms of depression with a baseline score of
Table 3 |Table showing levels of evidence for randomized controlled
trials (based on Oxford Center for Evidence-based Medicine).
Evidence level Study design
1 High quality RCTs with narrow confidence intervals
2 Low quality RCTs or high quality cohort studies
3 Case-control studies
4 Case series or poor case-control studies or poor
cohort studies or case reports
High quality RCTs are those having narrow confidence intervals and>80% follow-
up rate.
Low quality RCTS are those with wide confidence intervals,<80% follow-up rate.
The Center for Evidence-based Medicine additionally defines low quality cohort
studies as “those which have not clearly defined comparison groups and/or failed
to measure exposures and outcomes in the same (preferably blinded), objective
way in both exposed and non-exposed individuals and/or failed to identify or appro-
priately control known confounders and/or failed to carry out a sufficiently long
and complete follow-up of patients.”
>10 on the Geriatric Depression Scale (GDS) and suggested that
10 sessions of laughter yoga or exercise resulted in significant
improvement of depressive symptoms from baseline and com-
pared to a wait-list control group; however the two active treatment
groups did not differ from each other (Vedamurthachar et al.,
2006). The mild severity makes this study not generalizable to
more severe clinical depressives.
In a 24-week study comparing the effects of yoga (7 h weekly)
to Ayurveda and wait-list controls among 69 elderly individuals
(mean age of 72 years), with self-report of symptoms consistent
with depression and baseline mean scores on GDS corresponding
to mild illness severity who were not on psychotropic medications,
Krishnamurthy et al. reported that in the yoga group, there was a
reduction in the scores on the GDS, from the baseline mean score
of 10.6 by approximately 20% at 3 months and 40% at 6 months,
a change from mild depression to no depression. This was sta-
tistically superior to the Ayurveda and wait-list control groups,
neither of which demonstrated significant reduction in scores.
The main limitations were the potential group interaction ben-
efits of the yoga activity, lack of formal diagnoses according to
criteria specified by the Diagnostic and Statistic Manual of Mental
Disorders (DSM), relatively modest sample size, and the inclusion
of only mildly depressed individuals making it difficult to gener-
alize to more ill patients or to home based yoga (Krishnamurthy
and Telles, 2007).
In a study of depression in 60 alcohol dependents males (mean
age of approximately 35 years). Vedamurthachar et al. demon-
strated that subjects undergoing de-addiction treatment had a
statistically significant reduction in their scores on the Beck
Depression Inventory (BDI), and concurrent reduction in serum
cortisol levels when they received Sudarshan Kriya yoga (SKY)
compared to their counterparts receiving routine inpatient care
(Vedamurthachar et al., 2006). The BDI scores decreased by 75%
at the end of 7 days in the yoga group. The acute alcoholism diag-
nosis makes it to isolate the effects of yoga versus the effects of
alcohol detoxification, and further it was not clear if the sub-
jects met stringent criteria for major depression. While this study
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Table 4 |Table showing levels of recommendation.
Term Level Evidence levels Explanation
Recommended A 1 or 2 Assessment supported by a substantial amount of high quality (levels 1 or 2) evidence
and/or based on consensus of clinical judgment
Suggested B 1 or 2 – few studies Assessment supported by sparse high grade (Level 1 or 2) data or a substantial amount of
low grade (level 3 or 4) data and/or clinical consensus3 or 4 – many studies
and expert consensus
May be considered C 3 or 4 Assessment is supported by low grade data without the volume to recommend more
highly and likely subject to revision with further studies
documents only a possible acute effect of yoga, it does not provide
insights into longer term benefits.
A fourth study focused on treatment naive young adults (mean
age of 21.5 years) with self-reported symptoms of depression and
scores in the “mild mood disturbance” range on the BDI (Wool-
ery et al., 2004). Woolery et al. found that five weekly sessions of
Iyengar Yoga resulted in reduction in scores of depression, from a
mean of 12.77 to a mean of 3.90, a value categorized as“normal ups
and downs” at the end of 5 weeks, a statistically significant change
compared to controls with a score reduction from a mean of 12.07
to 11.0 at the end of the study period. A significant reduction in
anxiety and an increase in early morning cortisol level were also
reported in the yoga group (Woolery et al., 2004).
None of the studies encountered adverse events in the yoga
group though it was not always clear how systematically they were
sought for. The drop-out rates were 0% (Vedamurthachar et al.,
2006), approximately 27% (Krishnamurthy and Telles, 2007), and
14% (Woolery et al., 2004). Remission and relapse prevention
rates have not been determined by currently available studies.
Based on our assessment of the available literature according to
the RAND/UCLA Appropriateness method, Grade B evidence
supporting a potential acute benefit for yoga exists in depression.
YOGA FOR SCHIZOPHRENIA
Three RCTs examining the effects of yoga on schizophrenia have
been included in this review. Table 6 provides a summary. In a
study based at a state psychiatric facility, comprising 18 adult
patients (mean age of 37.4 in the yoga group and 48.1 among
controls, but without statistical significance in age distribution)
diagnosed with schizophrenia or schizoaffective disorder,Visceglia
et al. compared the effects of 8 weeks of yoga as an adjunct to
anti-psychotic medications with a control group receiving routine
inpatient care. The authors reported a reduction in the Positive and
Negative Syndrome Scale (PANSS) total score of 25.2 points, from
a baseline of 85.1 in the yoga group as well as reductions of 5.9, 6.0,
and 13.3 in the positive syndrome, negative syndrome, and General
psychopathology sub-scores, all of which were statistically supe-
rior to the controls. The secondary outcome measures of physical
health and psychological health were significantly improved in the
experimental group, as were informal reports of reduced aggres-
sion and improved medication compliance. The small sample
size, absence of a control intervention, wide range of function-
ality among participants, and the short duration of follow-up are
limitations of this study (Visceglia and Lewis, 2011).
Behere et al. compared the adjunctive effects of yoga with exer-
cise wait-list controls in their 3 month study of 91 anti-psychotic
stabilized adult outpatients with schizophrenia with baseline Clin-
ical Global Impression (CGI) score less than or equal to 3. The
authors reported reduction in PANSS positive and negative symp-
tom scores by 17 and 20%, respectively, statistically superior to the
other two groups, as well as significant improvements in facial
emotion recognition deficits, and socio-occupational function-
ing. Significantly higher baseline scores in the PANSS negative
sub-scale and facial emotional recognition deficit in the yoga
group, variation in the amount of yoga practice at home during
the last 2 months of the study, limited follow-up are drawbacks
of this study, and the inclusion of stable outpatients limit its
generalizability to more severely ill individuals (Behere et al.,
2011).
In a study of 61 anti-psychotic stabilized (mean dose of around
470 mg/day in Chlorpromazine equivalents) inpatients and out-
patients (mean age around 32 years) with schizophrenia (CGI
illness severity score of 4.8 and 5.2 in the yoga and control
groups) Duraiswamy et al. compared the effects of yoga with
exercise, as adjuncts to anti-psychotic medications. Participants
were taught yoga and exercise for 3 weeks, followed by encour-
agement of continued practice with monitoring of adherence.
The authors reported a reduction in the total PANSS score by
25.09 points, corresponding to a moderate-to-large effect size of
0.74 in the yoga group, a greater reduction in the negative sub-
scale (7.71 points, from a baseline of 21.9), but no statistically
significant change between the two groups in the positive sub-
scale. The yoga group demonstrated an improvement of socio-
occupational functioning, with an effect size of 0.48 in the Socio-
Occupational Functioning Scale (SOFS). Notable limitations of
the study include its modest sample size and unclear assessment
of continued home practice of the interventions (Duraiswamy
et al., 2007).
There were no adverse events, attributable to yoga reported in
any of the studies, although it is not clear how this assessment
had been performed. It is difficult to separate the effects of yoga
from the benefits of group interaction. Assessments of change in
the dose of anti-psychotics, relapse rates, and hospitalization rates
have not been performed in any of the existing studies. Based
on our assessment of the available literature according to the
RAND/UCLA Appropriateness method, Grade B evidence sup-
porting a potential benefit for yoga as an adjunct to anti-psychotic
treatment in chronic schizophrenia.
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YOGA FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Two RCTs examining the effects of yoga on Attention-Deficit
Hyperactivity Disorder (ADHD) have been included in this review
(Table 7). In a cross-over study of 19 children with mean age
around 10 years, diagnosed with ADHD meeting both Inter-
national Classification of Diseases-10 (ICD-10) and Diagnostic
and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria
(which included children with attention disorders, hyperkinetic
disorder of social behavior, and not otherwise specified hyperki-
netic disorder). Haffner et al. compared the effects of yoga with
“conventional motor exercises,” comprising of well known active
games as adjuncts to pharmacotherapy for 34 weeks. The authors
report superior efficacy of yoga with effect sizes of 0.77, 0.71, 0.60,
and 0.97 in the total scale, attention-deficit sub-scale, hyperactivity
sub-scale, and impulsiveness sub-scale, respectively, of a German
ADHD rating scale for parents and teachers. They also found a sig-
nificant sequence effect on the Dartmond Attention Test (DAT),
such that the group which performed yoga followed by motor
exercises showed a higher improvement in scores after yoga but
their mean score change at the end of the study was lower than the
other group, which according to the authors may indicate that the
performance gain after yoga was lost after the conventional motor
exercise intervention (Haffner et al., 2006). The modest sample
size, carry-over effects from the cross-over design, limited follow-
up, and exclusion of children with severe behavioral symptoms
which are frequently co-morbid with ADHD are limitations of the
study.
Jensen et al. compared the effects of yoga with a control group
comprising of games incorporating talking, listening, and shar-
ing equipment for 20 weeks in their cross-over study of 16 chil-
dren (mean age of 10.63 and 9.35 years in the yoga and control
groups), diagnosed with ADHD according to DSM-IV criteria
and continued on pharmacotherapy. They reported significant
post-intervention improvement in scores on the Conners’ Par-
ent Rating Scales (CPRS), namely the Oppositional (Cohen’s d of
0.77), Global index Emotional lability (Cohen’s d of 0.79), Global
Index Total (Cohen’s d of 0.73), Global Index Restless/Impulsive
(Cohen’s d of 0.73), ADHD index (Cohen’s d of 0.29), and Perfec-
tionism (Cohen’s d of 0.58) sub-scales but not in the Hyperactivity,
anxious/shy, and social problems sub-scales, where the controls
fared better. It is notable that neither group showed statistically sig-
nificant improvement in scores rated by teachers, and the authors
have suggested that this result may be obscured by the fact that
assessments in schools occur when children are medicated, while
that by parents is during unmedicated times. There were anecdotal
reports by parents, of improved homework compliance and yoga
being an effective calming technique during episodes or behavioral
escalation. The limited follow-up limits the understanding of the
maintenance effects of yoga (Jensen and Kenny, 2004).
Neither study has reported adverse events in the yoga group,
although it is not clear how side effect assessment was performed.
Details of pharmacotherapy for ADHD, change in dose during the
course of the study have not been provided. Based on our assess-
ment of the available literature according to the RAND/UCLA
Appropriateness method, Grade B evidence supporting a poten-
tial benefit for yoga as an adjunct to pharmacotherapy in ADHD
in children.
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FIGURE 2 | Literature search.
YOGA FOR EATING DISORDERS
Two RCTs examining the effects of yoga on eating disorders have
been included (Table 8). McIver et al. included 90 overweight or
obese women (mean age of 40.1 and 42 years in the yoga and con-
trol groups) with self-reported symptoms of binge eating (listed in
DSM-IV TR appendix) and a mean Binge Eating Scale (BES) score
of around 28, corresponding to severe binge eating. They reported
that BES score decreased by approximately 50% after 12 weeks of
yoga, corresponding to an improvement from“severe”binge eating
to the “absence” of binge eating, statistically superior to wait-list
controls who did not demonstrate any improvement. The authors
also report a lower attrition rate in the yoga group (26%) compared
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to controls (32%) and an increase in overall physical activity, mea-
sured by the International Physical Activity Questionnaire (IPAQ).
Limitations of this study include the procurement of data by self-
report, absence of details of concurrent pharmacotherapy in the
paper, and difficulty separating the true effects of yoga from that of
increased contact and attention received by the yoga group during
the course of the study. It would have been useful to assess whether
participants perceived yoga as a way of losing weight or for overall
mental health (McIver et al., 2009).
The second study in this group included 113 women (mean age
of 19.56 years) reportedly “dissatisfied with their bodies,” record-
ing mean baseline scores on the Eating Disorder Diagnostic Scale
(EDDS) of 26.34, 30, and 22.55 in the yoga, cognitive disso-
nance therapy, and wait-list control groups, respectively, where
a score> 16.5 is strongly suggestive of illness. The authors used a
number of outcome measurements (see Table 9), which include
assessments of eating disorder, binge eating, body shape percep-
tion, alexithymia, anxiety, and depression to compare the three
groups for a duration of 6 weeks. This study reported significant
improvement in the group which received therapy based on cog-
nitive dissonance, but not in the yoga or wait-list control groups
(Mitchell et al., 2007). Since only one study yielded positive results,
we did not grade the evidence for this category.
YOGA FOR SLEEP COMPLAINTS
Three RCTs examining the effects of yoga on sleep complaints
have been included in this review (Table 9). In their study of
139 ambulatory, community-dwelling, elderly (mean age of 69.2),
cognitively able participants without previous training in yoga.
Chen et al. compared the effects of yoga (three times a week for
6 months) to wait-list controls. The mean baseline total Pittsburgh
Sleep Quality Index (PSQI) scores were 4.65 and 5.47, respectively,
for yoga and control groups, where total score> 5 is associated
with poor sleep quality. The authors report a reduction in the total
PSQI score, through 4.48 at 3 months to 3.34 at 6 months in the
yoga group, statistically superior to controls who demonstrated
an increase in the score, implying poor outcome. The yoga group
also demonstrated statistically superior outcomes related to sleep
latency, day-time dysfunction, secondary outcomes of depression,
physical, and mental health perception, all of which reportedly
worsened among controls. The reliance on self-report for inclusion
in the study, absence of formal DSM diagnoses of either primary
or secondary insomnia, baseline mean score outside of the range
considered “poor sleep,” absence of information about use of sleep
aids limit the generalizability of these findings (Chen et al., 2009).
In a study conducted at a home for the aged in India, Manjunath
et al. compared the effects of 6 months of training in yoga versus
an ayurvedic preparation on 69 elderly subjects (mean age of 70.1,
72.1, and 72.3 in the yoga, ayurveda, and wait-list control groups)
with self-report of sleep impairment, but the absence of formal
diagnosis of a sleep disorder at baseline. The authors reported a
mean reduction in sleep latency of approximately 10 min and an
increase in duration of approximately 60 min in the yoga group,
a significant finding compared to the two control groups, nei-
ther of whom demonstrated comparable improvement. Of note,
the sleep latency was fairly high at 25.83 min in the yoga group,
even at the end of the study. The modest sample size, absence
of formal DSM diagnoses, the presence of statistical significance
within treatments but not between treatments for sleep latency are
notable limitations (Manjunath and Telles, 2005).
Cohen et al. examined the effects of seven weekly sessions
of Tibetan yoga (which combined training in breathing, relax-
ation, and postures with guided imagery), comparing it to wait-list
controls on 39 adults (mean age of 51 years) with lymphoma who
were either receiving chemotherapy or had received it within the
past 1 year. Participants reported subjective sleep impairment and
recorded baseline PSQI scores of 6.5 and 7.2, respectively, in the
yoga and control groups, corresponding to “poor sleep quality”
according to scoring guidelines. Formal DSM diagnoses of insom-
nia had not been established. The yoga group demonstrated a
statistically superior reduction in the total PSQI score, a reduction
from a mean of 6.5 to 5.8, compared to controls who recorded a
mean score of 8.1 at the end of the study. Scores of sleep qual-
ity (improved from 0.90 to 0.85), latency (improved from 1.10 to
0.75), and duration (improved from 0.85 to 0.89) were favorable
in the yoga group, whereas the controls did poorly on all of the
above parameters. The yoga group, but not controls showed a sta-
tistically significant reduction in the need for sleep aids – details
of agents used and doses have not been specified. While there was
improvement in sleep related parameters, depression, and state
anxiety did not change. The modest sample size, unclear distinc-
tion between primary sleep disorders and those secondary to a
mood, or anxiety disorder are drawbacks of this study (Cohen
et al., 2004).
None of the studies reported adverse effects attributable to yoga,
although it is not clear how they were assessed. Based on our assess-
ment of the available literature according to the RAND/UCLA
Appropriateness method, Grade C evidence supporting a potential
benefit for yoga exists for sleep complaints.
YOGA FOR COGNITION OR CONDITIONS INFLUENCING COGNITION
Two studies have been included in this review, the details of which
can be found on Table 10. Sharma et al. examined the adjunctive
effects of 8 weeks of yoga on neurocognitive functions in 30 adults
(age range between 18 and 45) meeting criteria for Major Depres-
sion, comparing it to a group which received only medications.
Outcomes included measures of working memory, executive func-
tion, visual attention, task switching ability, and visual scanning,
as outlined in Table 10. The authors report that while both groups
demonstrate improvement in the Letter Cancelation Test (LCT),
a measure of attention, concentration, and visuospatial function),
Trail making tests A and B (measures of visual attention and task
switching), the yoga group demonstrated superior results in LCT,
and separated from the controls in the Reverse digit span test
assessing short-term memory (Sharma et al., 2006). The modest
sample size, lack of information about the severity of depression
in the abstract are limitations and it is unclear if the improvement
in these measures of cognition in the yoga group are a direct effect
on cognition or secondary to greater improvement in depression
mediated through yoga.
In a study of 135 elderly individuals (mean age of 71.5, 73.6,
and 71.2 in the yoga, exercise, and wait-list groups, respectively).
Oken et al. compared the effects of yoga with exercise and wait-
list controls over 6 months, focusing on measures of alertness
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using EEG and the Stroop Color and word tests. Baseline cognitive
assessments are not reported to have been performed; individuals
with severe medical illnesses were excluded, as were those with
experience in yoga over the last 6 months. Significant changes
in measures of cognition were not demonstrated in any of the
groups. The yoga group did demonstrate improvement in quality
of life measures related to a sense of well-being as physical mea-
sures such as forward flexibility and timed one leg standing. The
negative results notwithstanding, the absence of specification of
baseline cognitive status is a drawback of this study (Oken et al.,
2006).
DISCUSSION
KEY FINDINGS
To our knowledge, this is the first review to systematically exam-
ine the published literature on benefits of yoga for several major
psychiatric illnesses. Based on our assessment of the available lit-
erature according to the RAND/UCLA Appropriateness method,
Grade B evidence supporting a potential acute benefit for yoga
exists in depression (four RCTs), as an adjunct to medications in
Schizophrenia (three RCTs) and ADHD (two RCTs), and Grade
C evidence supports the benefit of yoga for sleep complaints
(three RCTs).
Studies have found reasonable benefit in mild depression, even
in the absence of pharmacotherapy. Studies of yoga in schizophre-
nia have yielded evidence of benefit as an adjunct to medications
in improving positive and negative symptoms, quality of life,
and socio-occupational functioning. The RCTs examining yoga in
ADHD have demonstrated moderate-large effect sizes, compara-
ble according to the authors, to other alternative therapies such as
biofeedback and relaxation in ADHD (Haffner et al., 2006). Three
RCTs suggest substantial benefit for sleep complaints, although
the absence of formal DSM diagnoses in these studies is lim-
iting. RCTs in cognitive disorders and eating disorders yielded
conflicting results. Of note, Grade B implies that the assessment
is supported by sparse high grade data or a substantial amount
of low grade data and/or clinical consensus and Grade C suggests
that the assessment is supported by low grade data without the
volume to recommend more highly and likely subject to revision
with further studies (Fitch et al., 2000).
LIMITATIONS BASED ON SEARCH STRATEGY AND
INCLUSION/EXCLUSION CRITERIA
Although yoga has been used as a treatment for a wide variety
of psychiatric conditions and distress, we have focused on the
major broad categories of psychiatric disorders, namely depres-
sion, schizophrenia, eating disorders, ADHD, sleep complaints,
and cognitive impairments. We excluded studies on sub-threshold
symptoms such as coping, general well-being as well as studies
conducted on individuals without psychiatric diagnosis. This was
done to minimize the possibility that observed effects are merely a
reactive change to a new event in normal individuals. Our search
term “anxiety” yielded studies on post-traumatic stress, state, and
trait anxiety but these studies had specifically excluded individuals
with pre-established psychiatric diagnoses and hence did not make
it to the final review.
LIMITATIONS BASED ON STUDY METHODOLOGY
Few studies have provided details on how randomization had been
performed. Studies included in our review consist of various sub-
types of yoga and the description of the intensity of yoga has
not been specified in many studies. The number of studies for
each sub-type of yoga is very small, therefore, for the purpose
of our review, which is the first of its kind, we considered sub-
types which included similar basic components, namely controlled
breathing, relaxation, and postural training to be equivalent. Due
to the nature of the intervention, blinding of subjects is challeng-
ing, while information regarding blinding of the assessor has not
been provided in most studies. Analogous to other interventions
such as exercise, where they may be effects of group intervention, it
is difficult to isolate benefits of being in a group from that derived
from yoga alone in our studies. This may be particularly the case
in studies with wait-list controls, where it is difficult to establish
if the observed changes are due to the effect of yoga or merely
expectation. The sample sizes are small in many studies and the
generalizability of benefits noted in participants who demonstrate
the motivation to participate and comply in studies of yoga may be
questionable. The severity of illness has varied across studies, and
it is of concern if the findings from results of mildly ill individuals
(such as the depression studies) can be extrapolated to those with
severe illness. Although adverse effects have not been reported in
these studies, details of how the assessment had been done are
lacking.
CONCLUSION
Our systematic review finds emerging scientific evidence to sup-
port a role for yoga in treating depression, sleep complaints
consistent with both popular beliefs and biological studies, and
having adjunctive value in schizophrenia and ADHD. The evi-
dence in other disorders remains less well established. Given the
growing popularity of yoga, it would be important for the field
to attempt to replicate and extend these findings in larger, multi-
center, randomized, blinded (at least single blinded) studies with
the control group receiving alternative treatments,preferably using
Good clinical practice (GCP) guidelines. Biomarker research, such
as through functional magnetic resonance imaging (MRI) and
Positron Emission Tomography (PET) studies, and molecular
markers (genomics, metabolomics, and proteomics), would facil-
itate greater scientific understanding at a neurobiological level, of
this 5000-year-old revered practice.
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